Header cover image

U.S. Healthcare Sector Analysis

UpdatedFeb 05, 2023
DataAggregated Company Financials
Companies1595
  • 7D0.3%
  • 3M3.6%
  • 1Y-3.0%
  • YTD0.3%

The Healthcare is pretty flat in the last 7 days, but Stryker has stood out, gaining 11%. Furthermore, the industry has been flat for the past year as well. Looking forward, earnings are forecast to grow by 14% annually.

Sector Valuation and Performance

Has the U.S. Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 05 Feb 2023US$6.0tUS$2.5tUS$133.7b23.7x44.8x2.4x
Tue, 03 Jan 2023US$6.0tUS$2.5tUS$135.6b23.1x44.4x2.5x
Thu, 01 Dec 2022US$6.1tUS$2.4tUS$133.5b24x45.9x2.5x
Sat, 29 Oct 2022US$5.9tUS$2.4tUS$149.1b23x39.7x2.4x
Mon, 26 Sep 2022US$5.5tUS$2.4tUS$155.9b20.7x35.4x2.3x
Wed, 24 Aug 2022US$5.9tUS$2.4tUS$157.2b23x37.4x2.4x
Fri, 22 Jul 2022US$6.0tUS$2.6tUS$165.2b25.2x36.1x2.3x
Sun, 19 Jun 2022US$5.4tUS$2.6tUS$166.0b23.1x32.5x2.1x
Tue, 17 May 2022US$5.7tUS$2.6tUS$164.5b25x34.9x2.2x
Thu, 14 Apr 2022US$6.5tUS$2.5tUS$175.5b29.4x37.3x2.6x
Sat, 12 Mar 2022US$6.1tUS$2.5tUS$170.7b27.4x35.6x2.5x
Mon, 07 Feb 2022US$6.3tUS$2.4tUS$161.9b29.6x38.9x2.6x
Wed, 05 Jan 2022US$6.8tUS$2.4tUS$145.5b32.1x46.4x2.8x
Fri, 03 Dec 2021US$6.5tUS$2.4tUS$146.5b30.9x44.4x2.7x
Sun, 31 Oct 2021US$6.9tUS$2.3tUS$129.9b32.6x53x2.9x
Tue, 28 Sep 2021US$6.8tUS$2.3tUS$120.0b36.1x56.6x2.9x
Thu, 26 Aug 2021US$6.9tUS$2.3tUS$121.2b32.3x56.8x3x
Fri, 02 Jul 2021US$6.6tUS$2.3tUS$113.6b32.4x57.7x2.9x
Mon, 05 Apr 2021US$6.0tUS$2.4tUS$93.5b29x64.1x2.5x
Thu, 07 Jan 2021US$5.8tUS$2.3tUS$87.0b29.3x66.5x2.5x
Wed, 30 Sep 2020US$5.1tUS$2.3tUS$104.6b28.7x49.1x2.3x
Sat, 04 Jul 2020US$4.8tUS$2.4tUS$101.2b31.4x47.4x2x
Tue, 07 Apr 2020US$3.9tUS$2.4tUS$99.2b28.8x39x1.6x
Price to Earnings Ratio

38.9x


Total Market Cap: US$4.1tTotal Earnings: US$105.0bTotal Revenue: US$2.3tTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Healthcare Sector Price to Earnings3Y Average 48.2x202120222023
Current Industry PE
  • Investors are pessimistic on the American Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 44.9x which is lower than its 3-year average PE of 48.2x.
  • The industry is trading close to its 3-year average PS ratio of 2.4x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 8.4% per year over the last three years.
  • Revenues for these companies have grown 2.5% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare sector?

US Market1.73%
Healthcare0.31%
Healthtech4.38%
Medical Equipment3.76%
Life Sciences1.68%
Pharma-0.54%
Biotech-0.83%
Healthcare Services-2.05%
Industry PE
  • Investors are most optimistic about the Biotech industry which is trading above its 3-year average PE ratio.
    • Analysts are expecting annual earnings growth of 14.1%, which is lower than the prior year's growth of 53.0% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 36% over the next 5 years.
  • This is better than its past earnings growth rate of 29% per year.
  • In contrast, the Pharma industry is expected to see its earnings grow by 10% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SYK StrykerUS$283.1411.4%
+US$11.0b
12.8%PE45.4x
MDT MedtronicUS$87.105.5%
+US$6.0b
-15.2%PE26.8x
ALGN Align TechnologyUS$343.1027.5%
+US$5.8b
-30.0%PE74.1x
TMO Thermo Fisher ScientificUS$587.762.5%
+US$5.6b
-1.1%PE33.3x
BMY Bristol-Myers SquibbUS$74.452.8%
+US$4.4b
14.6%PE26.1x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

REGN

US$783.13

Regeneron Pharmaceuticals

7D

5.4%

1Y

25.7%

BMY

US$74.45

Bristol-Myers Squibb

7D

2.8%

1Y

14.6%

MRNA

US$173.25

Moderna

7D

-8.5%

1Y

6.3%

MRK

US$102.94

Merck

7D

-2.3%

1Y

31.0%

BSX

US$48.50

Boston Scientific

7D

5.6%

1Y

13.4%

CI

US$292.59

Cigna

7D

-5.1%

1Y

32.2%

ALGN

US$343.10

Align Technology

7D

27.5%

1Y

-30.0%

MCK

US$362.58

McKesson

7D

-4.4%

1Y

36.5%

AMGN

US$245.17

Amgen

7D

-3.3%

1Y

10.4%

TMO

US$587.76

Thermo Fisher Scientific

7D

2.5%

1Y

-1.1%

VRTX

US$301.02

Vertex Pharmaceuticals

7D

-6.4%

1Y

24.4%